All
FDA Publishes Guidance on Biopharmaceutics Classification System-Based Biowaivers
May 20th 2021The guidance document gives recommendations to support biopharmaceutics classification of drug substances and the Biopharmaceutics Classification System-based waiver of the in-vivo bioequivalence study requirement for drugs.
Pfizer and BioNTech to Supply EU with Up to 1.8 Billion Additional COVID-19 Vaccine Doses
May 20th 2021Pfizer and BioNTech have entered into a new agreement with the European Commission to supply 900 million doses of Comirnaty to the European Union with an option to request up to 900 million additional doses.
Bristol Myers Squibb Enters into Agreement with Agenus for Up to $1.56 Billion
May 19th 2021Bristol Myers Squibb has entered into a definitive agreement with Agenus for a global exclusive license to Agenus’ proprietary bispecific antibody program, AGEN1777, that blocks TIGIT and a second undisclosed target.
Biogen and Capsigen to Develop Novel AAV Capsids for up to $1.37 Billion
May 12th 2021Biogen and Capsigen have entered into a strategic research collaboration to engineer novel AAV capsids to deliver gene therapies that address the underlying genetic causes of various central nervous system and neuromuscular disorders.
Sterling Pharma Solutions and OncoTEX to Develop Novel Treatment Against Ovarian Cancer
May 11th 2021Sterling Pharma Solutions and OncoTEX have entered into a clinical development agreement for the manufacturing of OncoTex’s novel platinum-resistant oncology drug candidate, OxaliTEX, for use in clinical trials.